Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Business Gazette Online.
Press releases published on May 5, 2025

Fabrinet Announces Third Quarter Fiscal Year 2025 Financial Results
Record Third Quarter Revenue Exceeds Guidance Range BANGKOK, May 05, 2025 (GLOBE NEWSWIRE) -- Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original …

T1 Energy Announces First Quarter 2025 Earnings Release and Conference Call Schedule
AUSTIN, Texas and NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this afternoon that the Company will publish a press release detailing first quarter 2025 results and conduct a …

Interparfums, Inc. Reports 2025 First Quarter Results
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the first quarter ended March 31, 2025. First Quarter Highlights: ($ in millions, except per share amounts) Three Months Ended March 31, 2025 2024 % …

Onity Group to Present at Upcoming Investor Conferences
WEST PALM BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that executive management will participate in two upcoming conferences in May 2025. Glen Messina, Chair, President and Chief …

Lamar Advertising to appear at the 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference
BATON ROUGE, La., May 05, 2025 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a question-and-answer session at the 53rd Annual J.P. Morgan …

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update
Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June Initial Phase 2 data for rosnilimab in …

Certara Reports First Quarter 2025 Financial Results
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 …

Dogecoin Whales have Accumulated about 100 million DOGE tokens While Trader’s Eyes are on PaladinMining to Earn Massive Returns
London, UK, May 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin continues to show bullish signals while 100 million DOGE tokens accumulated by the whales have further strengthened it – making it highly desirable for traders. As Crypto analysts suggest a price surge …

Aterian Sets Date for First Quarter 2025 Earnings Announcement & Investor Conference Call
SUMMIT, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a technology-enabled consumer products company, today announced that it will issue its financial results for the first quarter ended March 31, 2025 on …

Palomar Holdings, Inc. Reports First Quarter 2025 Results
LA JOLLA, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $42.9 million, or $1.57 per diluted share, for the first quarter of 2025 compared to net income of $26.4 million, or $1. …

Shoals Technologies Group, UGT Renewables and Sun Africa Announce Collaboration on up to 12GW of Solar Projects
PORTLAND, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the execution of a Memorandum of …

Vornado Completes Master Lease with New York University for 770 Broadway
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that it has completed a master lease with New York University (“NYU”) to lease 1,076,000 square feet at 770 Broadway, on an “as is”, triple net basis for a 70-year …

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance
First Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9% U.S. revenue of $44.8 million, representing growth of 26.6% Gross margin of 79.7%, representing an …

Hudbay Publishes 2024 Annual Report, “Built to Grow”
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the release of its 2024 annual report (“Annual Report”) which provides insight and transparency on key business, operating and …

Context Therapeutics Announces Chief Medical Officer Transition
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

James River Announces Excess and Surplus Lines Leadership Retirement and Succession Plan
PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) announced today its plans for Todd Sutherland, current Senior Vice President, Management Liability within the Company’s …

Mission Produce® Appoints Michael Sims to Board of Directors
OXNARD, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today …

ThredUp Announces First Quarter 2025 Results
All results reported are for continuing operations, unless otherwise noted. Record quarterly revenue of $71.3 million, representing an increase of 10% year-over-year Quarterly gross margin of 79.1% and an increase in gross profit of 9% year-over-year …

James River Announces First Quarter 2025 Results
PEMBROKE, Bermuda, May 05, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported net income from continuing operations available to common shareholders of $9.0 million ($0.18 per diluted share) …

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …